Clinical updates, including trial initiations, enrollment status and data readouts and publications: Active Biotech, Aeromics, Angion, Beigene, Carrick, Clene, Eucure, Gilead, Immunic, Moderna, Obseva, Roche, Simcere, UCB, Vifor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Affimed, Aligos, Ambrx, Astrazeneca, Atara, Aurinia, Daiichi Sankyo, Frequency, Cincor, India Globalization Capital, Ionctura, Iteos, Iterion, Mitsubishi, Rhovac,Samsung Bioepis, Sanofi, Scilex, Sciwind, SQZ, Uniqure, Vir, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affimed, Amphera, Biogen, Celldex, Eisai, Glaxosmithkline, Henlius, I-Mab, Index, LB, Lexaria, Medicago, Merck, Monopar, MRM, Neurocrine, Novabiotics, Novartis, Radius, Sage, Sorrento, Takeda, Tranquis, Treadwell.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acadia, Aligos, Anthos, Astrazeneca, Blueprint, Can-Fite, Daiichi, Ideaya, Innovent, Inventiva, Janssen, Meiragtx, Noxxon, Prometheus, Puretech, Recce, Revalesio, Vaccitech.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acurx, Aeglea, Bavarian Nordic, Biohaven, Catalyst, Citius, Cyxone, Dydo, Glycomimetics, Hutchmed, Implicit, J&J, Karyopharm, Kazia, Kronos, Mediwound, Mesoblast, Nrx, Ocular, PDS, Ventyx, Xenon, ZZ.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adagene, Adicet, Astrazeneca, Bayer, Bellicum, Biofrontera, Bolt, Eupraxia, Fulcrum, Hummingbird, I-Mab, Immunicum, Immunocore, Janssen, Merus, Neurona, Revive, Scynexis, Springworks, Stoke, Surface Oncology, Viacyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 180 Life Sciences, Acasti, Amgen, Arbutus, Arca, Bonus, Hepagene, Humanigen, India Globalization, Immutep, Karyopharm, Redhill, Revelation, Spago, VBI, Ysopia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Acadia, Accutar, Arch, Biogen, Ciclomed, Clene, Compass, Edesa, G1, Immunomic, Insilico, J&J, Lintonpharm, Longeveron, Lynk, Mina, Modus, Notable, Oncotelic, Peptilogics, Pulmotech, Rallybio, SAB, Sage, Scholar Rock, Selecta, Sobi, Vertex, Virios, Zai, Zymeworks.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Allakos, Anji, Astrazeneca, Axial, Blade, Daiichi, Ensysce, First Wave, Hoth, Immunogen, IMV, Isarna, Jazz, Kintara, Kyowa, Mei, Mereo, Nicox, Olema, Ose, Seres, Synact, Visus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Betterlife, Biocryst, Brainstorm, Clover, G1 Therapeutics, Kineta, Kronos, Krystal, Merck & Co., Neurana, Nrx, RDIF, Ridgeback, Springworks, Starpharma, Tetra, Ultragenyx.